Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71


Resistance of uropathogens to antibacterial agents: Emerging threats, trends and treatments.

Perletti G, Magri V, Cai T, Stamatiou K, Trinchieri A, Montanari E.

Arch Ital Urol Androl. 2018 Jun 30;90(2):85-96. doi: 10.4081/aiua.2018.2.85.


Computer-Assisted Quantitative Assessment of Prostatic Calcifications in Patients with Chronic Prostatitis.

Boltri M, Magri V, Montanari E, Perletti G, Trinchieri A.

Urol Int. 2018;100(4):450-455. doi: 10.1159/000486346. Epub 2018 Apr 26.


Automated classification of focal breast lesions according to S-detect: validation and role as a clinical and teaching tool.

Di Segni M, de Soccio V, Cantisani V, Bonito G, Rubini A, Di Segni G, Lamorte S, Magri V, De Vito C, Migliara G, Bartolotta TV, Metere A, Giacomelli L, de Felice C, D'Ambrosio F.

J Ultrasound. 2018 Jun;21(2):105-118. doi: 10.1007/s40477-018-0297-2. Epub 2018 Apr 21.


The association between prostatitis and prostate cancer. Systematic review and meta-analysis.

Perletti G, Monti E, Magri V, Cai T, Cleves A, Trinchieri A, Montanari E.

Arch Ital Urol Androl. 2017 Dec 31;89(4):259-265. doi: 10.4081/aiua.2017.4.259.


Chlamydia trachomatis versus common uropathogens as a cause of chronic bacterial prostatitis: Is there any difference? Results of a prospective parallel-cohort study.

Cai T, Pisano F, Nesi G, Magri V, Verze P, Perletti G, Gontero P, Mirone V, Bartoletti R.

Investig Clin Urol. 2017 Nov;58(6):460-467. doi: 10.4111/icu.2017.58.6.460. Epub 2017 Oct 31.


EpCAM-expressing circulating tumor cells in colorectal cancer.

Nicolazzo C, Raimondi C, Francescangeli F, Ceccarelli S, Trenta P, Magri V, Marchese C, Zeuner A, Gradilone A, Gazzaniga P.

Int J Biol Markers. 2017 Oct 31;32(4):e415-e420. doi: 10.5301/ijbm.5000284.


Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab.

Caponnetto S, Iannantuono GM, Barchiesi G, Magri V, Gelibter A, Cortesi E.

Oncology. 2017;93(1):62-66. doi: 10.1159/000464328. Epub 2017 Apr 14.


Affective disorders and Health-Related Quality of Life (HRQoL) in adolescents and young adults with Multiple Sclerosis (MS): the moderating role of resilience.

Rainone N, Chiodi A, Lanzillo R, Magri V, Napolitano A, Morra VB, Valerio P, Freda MF.

Qual Life Res. 2017 Mar;26(3):727-736. doi: 10.1007/s11136-016-1466-4. Epub 2016 Dec 7.


Eribulin in Male Patients With Breast Cancer: The First Report of Clinical Outcomes.

Giotta F, Acito L, Candeloro G, Del Medico P, Gadaleta-Caldarola G, Giordano G, Gueli R, Lugini A, Magri V, MandarĂ  M, Masci G, Pisconti S, Pistelli M, Rizzi A, Salesi N, Schirone A, Scognamiglio G, Tedeschi M, Zucchinelli P.

Oncologist. 2016 Nov;21(11):1298-1305. doi: 10.1634/theoncologist.2016-0022. Epub 2016 Oct 14.


Aminoglycoside antibiotics for NIH category II chronic bacterial prostatitis: A single-cohort study with one-year follow-up.

Magri V, Montanari E, Marras E, Perletti G.

Exp Ther Med. 2016 Oct;12(4):2585-2593. Epub 2016 Aug 30.


Multiparametric magnetic resonance imaging characteristics of normal, benign and malignant conditions in the prostate.

De Visschere PJ, Vral A, Perletti G, Pattyn E, Praet M, Magri V, Villeirs GM.

Eur Radiol. 2017 May;27(5):2095-2109. doi: 10.1007/s00330-016-4479-z. Epub 2016 Aug 4.


Safety analysis, association with response and previous treatments of everolimus and exemestane in 181 metastatic breast cancer patients: A multicenter Italian experience.

Moscetti L, Vici P, Gamucci T, Natoli C, Cortesi E, Marchetti P, Santini D, Giuliani R, Sperduti I, Mauri M, Pizzuti L, Mancini ML, Fabbri MA, Magri V, Iezzi L, Sini V, D'Onofrio L, Mentuccia L, Vaccaro A, Ramponi S, Roma CL, Ruggeri EM.

Breast. 2016 Oct;29:96-101. doi: 10.1016/j.breast.2016.07.005. Epub 2016 Jul 29.


Herbal medicines for urinary stone treatment. A systematic review.

Monti E, Trinchieri A, Magri V, Cleves A, Perletti G.

Arch Ital Urol Androl. 2016 Mar 31;88(1):38-46. doi: 10.4081/aiua.2016.1.38. Review.


Natural history of human papillomavirus infection in non-vaccinated young males: low clearance probability in high-risk genotypes.

Cai T, Perletti G, Meacci F, Magri V, Verze P, Palmieri A, Mazzoli S, Santi R, Nesi G, Mirone V, Bartoletti R.

Eur J Clin Microbiol Infect Dis. 2016 Mar;35(3):463-9. doi: 10.1007/s10096-015-2562-z. Epub 2016 Jan 11.


The promise of liquid biopsy in cancer: a clinical perspective.

Cortesi E, Palleschi M, Magri V, Naso G.

Chin J Cancer Res. 2015 Oct;27(5):488-90. doi: 10.3978/j.issn.1000-9604.2015.10.01.


Quality of life and cognitive functions in early onset multiple sclerosis.

Lanzillo R, Chiodi A, Carotenuto A, Magri V, Napolitano A, Liuzzi R, Costabile T, Rainone N, Freda MF, Valerio P, Brescia Morra V.

Eur J Paediatr Neurol. 2016 Jan;20(1):158-63. doi: 10.1016/j.ejpn.2015.08.005. Epub 2015 Sep 3.


Efficacy and safety of second-line agents for treatment of metastatic castration-resistant prostate cancer progressing after docetaxel. A systematic review and meta-analysis.

Perletti G, Monti E, Marras E, Cleves A, Magri V, Trinchieri A, Rennie PS.

Arch Ital Urol Androl. 2015 Jul 7;87(2):121-9. doi: 10.4081/aiua.2015.2.121. Review.


Multimodal therapy for category III chronic prostatitis/chronic pelvic pain syndrome in UPOINTS phenotyped patients.

Magri V, Marras E, Restelli A, Wagenlehner FM, Perletti G.

Exp Ther Med. 2015 Mar;9(3):658-666. Epub 2014 Dec 19.


Chlamydia trachomatis infection is related to premature ejaculation in chronic prostatitis patients: results from a cross-sectional study.

Cai T, Pisano F, Magri V, Verze P, Mondaini N, D'Elia C, Malossini G, Mazzoli S, Perletti G, Gontero P, Mirone V, Bartoletti R.

J Sex Med. 2014 Dec;11(12):3085-92. doi: 10.1111/jsm.12699. Epub 2014 Sep 25.


Supplemental Content

Support Center